Friday, April 27, 2018
News Recap:
Warnings:
Synthetic cannabinoids and Hepatitis A could be a fatal combination. On April 9, 2018, the Missouri Department of Health and Senior Services (DHSS) issued a news release – “Use of Synthetic Cannabinoids Linked to Severe Bleeding in the US,” informing the public about the national outbreak of bleeding illnesses among those consuming synthetic cannabinoids which appear to have been contaminated with a long-...
11 April 2018, Paris, France: Two independent studies have today reported that alcoholic liver disease has now replaced hepatitis C virus (HCV) infection as the leading cause of liver transplantation in the USA in patients without HCC. Non-alcoholic steatohepatitis (NASH) is also on the increase, now ranking second as a cause of liver transplantation due to chronic liver disease.
Chronic HCV infection has remained the leading indication for liver transpla...
EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER -- 11 April 2018, Paris, France: Two independent studies have today reported that alcoholic liver disease has now replaced hepatitis C virus (HCV) infection as the leading cause of liver transplantation in the USA in patients without HCC. Non-alcoholic steatohepatitis (NASH) is also on the increase, now ranking second as a cause of liver transplantation due to chronic liver disease.
Chronic HCV infection
Friday, January 19, 2018
News Recap:
Research & Discoveries:
Blood test for early detection of 8 cancers looks promising. Scientists have developed a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. The test, called CancerSEEK, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast. CancerSEEK tests wer...
Patients who underwent liver transplantation evaluation had a high prevalence of coronary artery disease, especially those with nonalcoholic steatohepatitis-related cirrhosis, hepatitis C-related cirrhosis and alcoholic cirrhosis, according to a recently published study.
An integral component of the liver transplant evaluation (LTE) is coronary artery disease (CAD) assessment as surgical morbidity and mortality can be as high as 81% and 50%, respectively,
Friday, July 28, 2017
News Recap
WHD 2017 Victoria, BC in Pictures
The weather was perfect; the organization and volunteers did great!!!! The speakers were fabulous!! I only wish more people had shown up!!! Big thanks to VPWAS and AVI for helping to make this important event a reality! Click on photos to see larger image in a new window!
Should we be worried about hepatitis E?
Hepatitis E virus infection (HEV) is the most common cause of a...
Liver transplant indications vary depending on disease — from hepatitis C, to alcoholic liver disease, to cholestatic diseases such as primary biliary cholangitis and primary sclerosing cholangitis.
Healio.com/Hepatology presents the top liver transplant studies for July 2017, which include an online app designed to predict cardiovascular complication posttransplant, higher rates of donation among patients with risk exceptions in Eurotransplant countries,
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation. Doctors at Intermountain Medical Center in Salt Lake City have found a way to safely use a damaged liver to replace a dying liver, then cure the damaged liver of its disease.
Intermountain Medical Center is the first transplant center in the nation to use a revolutionary approach for saving the life of patients who are on death's d...
Findings might help reduce organ waiting list, researchers say
WebMD News from HealthDay
By Robert Preidt
HealthDay Reporter
THURSDAY, April 14, 2016 (HealthDay News) -- Here's some potentially good news for people with hepatitis C who are waiting for liver transplants: Hepatitis C-infected livers seem to do as well as healthy livers in these patients, a new study indicates.
The findings suggest that using hepatitis C-infected (HCV-positive) livers
Transplant
Liver Transplant Patient & Family with Surgeon
Liver Transplant is a rare option, and many people die while on the transplant list. While most HCV+ liver transplants are from cadavers, we present some information below about living donor transplants as well.
Also take a look at information for organ donors here.
After a liver transplant, HCV+ recipient
